SCHEMBL30133901

SCHEMBL30133901

CON(C)C(=O)c1ccc2nc(C)cnc2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 2/20 0.41
ALDH1A1 P00352 6/20 0.40
HPGD P15428 5/20 0.40
LMNA P02545 2/20 0.40
MLYCD O95822 1/20 0.40
HTT P42858 2/20 0.39
TDP1 Q9NUW8 2/20 0.39
RECQL P46063 1/20 0.39
CYP3A4 P08684 1/20 0.39
CYP2C9 P11712 1/20 0.39
ALOX12 P18054 1/20 0.39
CYP2C19 P33261 1/20 0.39
NPSR1 Q6W5P4 1/20 0.39
HPGDS O60760 2/20 0.38
F2 P00734 1/20 0.36
GLA P06280 1/20 0.36
MAPT P10636 2/20 0.36
KDM4E B2RXH2 1/20 0.36
MCOLN3 Q8TDD5 1/20 0.36
NPC1 O15118 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30133934 0.94 POLB (0.41) POLBALDH1A1HPGDLMNAMLYCD
SCHEMBL19051255 0.85 ALDH1A1 (0.41) POLBALDH1A1HPGDLMNAMLYCD
SCHEMBL1644909 0.81 POLB (0.56) POLBALDH1A1HPGDLMNAMLYCD
SCHEMBL31201715 0.80 CYP1A2 (0.45) POLBALDH1A1LMNAMLYCDHTT
SCHEMBL14783903 0.80 HPGD (0.42) POLBALDH1A1HPGDLMNAMLYCD
SCHEMBL14716207 0.80 ALDH1A1 (0.41) POLBALDH1A1HPGDLMNAMLYCD
SCHEMBL30134027 0.78 POLB (0.44) POLBALDH1A1HPGDLMNAMLYCD
SCHEMBL2629411 0.77 TDP1 (0.64) POLBALDH1A1HPGDHTTTDP1
SCHEMBL30134026 0.77 TDP1 (0.46) ALDH1A1HPGDLMNAHTTTDP1
SCHEMBL29985396 0.77 TDP1 (0.64) POLBALDH1A1HPGDHTTTDP1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119119033-A Pyrazolopyridone compounds 百济神州有限公司 2024-12-13 CN disclosed
US-20240300951-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-09-12 US disclosed
US-20240270751-A1 Pyrazolopyridinone Compounds BEIGENE LTD. (KY) 2024-08-15 US disclosed
EP-4380936-A1 PYRAZOLOPYRIDINONE COMPOUNDS BeiGene, Ltd. (KY) 2024-06-12 EP disclosed
WO-2023011456-A1 PYRAZOLOPYRIDINONE COMPOUNDS BEIGENE, LTD. (KY) 2023-02-09 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20240300951-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK POLB 1119/4885ALDH1A1 1296/4885HPGD 1034/4885
US-20240270751-A1 Pyrazolopyridinone Compounds NFATC1, CD4, PBK POLB 1119/4885ALDH1A1 1296/4885HPGD 1034/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.